A mouse model of intracellular iron deficiency achieved by targeted knock-in of a hepcidin-resistant isoform of the iron export protein ferroportin develops pulmonary hypertension, which can be prevented and reversed by intravenous iron (22). This evidence concerns the gene HAMP and pulmonary arterial hypertension.